Stalla, G. K. Max Planck Institute of Psychiatry, Max Planck Society;
Berg, C., Petersenn, S., Lahner, H., Herrmann, B. L., Buchfelder, M., Droste, M., et al. (2010). The Effect of Pegvisomant on Cardiovascular Risk in Patients with Active Acromegaly in Comparison to Matched Data from the General Population. Endocrine Reviews, 31(3 Suppl. 1), S857-S857.